Plasma Arginine Vasopressin in Hyponatremic Patients with Heart Failure

To the Editor: We offer the following comments in reference to the paper by Szatalowicz et al. 1 in the July 30 issue, reporting detectable arginine vasopressin (AVP) levels in some hyponatremic patients with heart failure. Although 3.04±0.84 pg per milliliter was the mean value for AVP in the group...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1981-12, Vol.305 (24), p.1470-1472
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1472
container_issue 24
container_start_page 1470
container_title The New England journal of medicine
container_volume 305
description To the Editor: We offer the following comments in reference to the paper by Szatalowicz et al. 1 in the July 30 issue, reporting detectable arginine vasopressin (AVP) levels in some hyponatremic patients with heart failure. Although 3.04±0.84 pg per milliliter was the mean value for AVP in the group with "detectable" levels, this number is somewhat misleading because of the presence of several very high values. Two thirds of the levels were actually below 2.0 pg per milliliter, and half of those were under 1.0 pg per milliliter. Thus, in most subjects, even in this group, AVP was nearly completely . . .
doi_str_mv 10.1056/NEJM198112103052412
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73747464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73747464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c336t-5c46b4a9a7991e492d6f14cd18074f63ca022a3510d3904fbd2e6e68e7c848303</originalsourceid><addsrcrecordid>eNp9kE1LwzAYx4Moc04_gQg9eZHqkyZNmuMYe1Gm7qBeS5Y-1YymnUmL7Ntb2fAkPvzhOfxfDj9CLincUkjF3dP04ZGqjNKEAoM04TQ5IkOaMhZzDuKYDAGSLOZSsVNyFsIG-qNcDchAMoBMyCGZryodnI7G_t3WtsboTYdm6zEEW0e9FrttU-vWo7MmWunWYt2G6Mu2H9ECtW-jmbZV5_GcnJS6Cnhx-CPyOpu-TBbx8nl-PxkvY8OYaOPUcLHmWmmpFEWukkKUlJuCZiB5KZjRkCSapRQKpoCX6yJBgSJDaTKeMWAjcr3f3frms8PQ5s4Gg1Wla2y6kEsmueSC90G2DxrfhOCxzLfeOu13OYX8B1_-B76-dXWY79YOi9_OgVfv3-x950Je48b9u_YNpQF10Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73747464</pqid></control><display><type>article</type><title>Plasma Arginine Vasopressin in Hyponatremic Patients with Heart Failure</title><source>MEDLINE</source><source>ProQuest Central UK/Ireland</source><description>To the Editor: We offer the following comments in reference to the paper by Szatalowicz et al. 1 in the July 30 issue, reporting detectable arginine vasopressin (AVP) levels in some hyponatremic patients with heart failure. Although 3.04±0.84 pg per milliliter was the mean value for AVP in the group with "detectable" levels, this number is somewhat misleading because of the presence of several very high values. Two thirds of the levels were actually below 2.0 pg per milliliter, and half of those were under 1.0 pg per milliliter. Thus, in most subjects, even in this group, AVP was nearly completely . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM198112103052412</identifier><identifier>PMID: 7300867</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Animals ; Arginine Vasopressin - blood ; Dogs ; Heart Failure - blood ; Heart Failure - complications ; Humans ; Hyponatremia - blood ; Hyponatremia - etiology</subject><ispartof>The New England journal of medicine, 1981-12, Vol.305 (24), p.1470-1472</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c336t-5c46b4a9a7991e492d6f14cd18074f63ca022a3510d3904fbd2e6e68e7c848303</citedby><cites>FETCH-LOGICAL-c336t-5c46b4a9a7991e492d6f14cd18074f63ca022a3510d3904fbd2e6e68e7c848303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908,64368</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7300867$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><title>Plasma Arginine Vasopressin in Hyponatremic Patients with Heart Failure</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>To the Editor: We offer the following comments in reference to the paper by Szatalowicz et al. 1 in the July 30 issue, reporting detectable arginine vasopressin (AVP) levels in some hyponatremic patients with heart failure. Although 3.04±0.84 pg per milliliter was the mean value for AVP in the group with "detectable" levels, this number is somewhat misleading because of the presence of several very high values. Two thirds of the levels were actually below 2.0 pg per milliliter, and half of those were under 1.0 pg per milliliter. Thus, in most subjects, even in this group, AVP was nearly completely . . .</description><subject>Animals</subject><subject>Arginine Vasopressin - blood</subject><subject>Dogs</subject><subject>Heart Failure - blood</subject><subject>Heart Failure - complications</subject><subject>Humans</subject><subject>Hyponatremia - blood</subject><subject>Hyponatremia - etiology</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LwzAYx4Moc04_gQg9eZHqkyZNmuMYe1Gm7qBeS5Y-1YymnUmL7Ntb2fAkPvzhOfxfDj9CLincUkjF3dP04ZGqjNKEAoM04TQ5IkOaMhZzDuKYDAGSLOZSsVNyFsIG-qNcDchAMoBMyCGZryodnI7G_t3WtsboTYdm6zEEW0e9FrttU-vWo7MmWunWYt2G6Mu2H9ECtW-jmbZV5_GcnJS6Cnhx-CPyOpu-TBbx8nl-PxkvY8OYaOPUcLHmWmmpFEWukkKUlJuCZiB5KZjRkCSapRQKpoCX6yJBgSJDaTKeMWAjcr3f3frms8PQ5s4Gg1Wla2y6kEsmueSC90G2DxrfhOCxzLfeOu13OYX8B1_-B76-dXWY79YOi9_OgVfv3-x950Je48b9u_YNpQF10Q</recordid><startdate>19811210</startdate><enddate>19811210</enddate><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19811210</creationdate><title>Plasma Arginine Vasopressin in Hyponatremic Patients with Heart Failure</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c336t-5c46b4a9a7991e492d6f14cd18074f63ca022a3510d3904fbd2e6e68e7c848303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Animals</topic><topic>Arginine Vasopressin - blood</topic><topic>Dogs</topic><topic>Heart Failure - blood</topic><topic>Heart Failure - complications</topic><topic>Humans</topic><topic>Hyponatremia - blood</topic><topic>Hyponatremia - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma Arginine Vasopressin in Hyponatremic Patients with Heart Failure</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1981-12-10</date><risdate>1981</risdate><volume>305</volume><issue>24</issue><spage>1470</spage><epage>1472</epage><pages>1470-1472</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>To the Editor: We offer the following comments in reference to the paper by Szatalowicz et al. 1 in the July 30 issue, reporting detectable arginine vasopressin (AVP) levels in some hyponatremic patients with heart failure. Although 3.04±0.84 pg per milliliter was the mean value for AVP in the group with "detectable" levels, this number is somewhat misleading because of the presence of several very high values. Two thirds of the levels were actually below 2.0 pg per milliliter, and half of those were under 1.0 pg per milliliter. Thus, in most subjects, even in this group, AVP was nearly completely . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>7300867</pmid><doi>10.1056/NEJM198112103052412</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 1981-12, Vol.305 (24), p.1470-1472
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_73747464
source MEDLINE; ProQuest Central UK/Ireland
subjects Animals
Arginine Vasopressin - blood
Dogs
Heart Failure - blood
Heart Failure - complications
Humans
Hyponatremia - blood
Hyponatremia - etiology
title Plasma Arginine Vasopressin in Hyponatremic Patients with Heart Failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T13%3A11%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20Arginine%20Vasopressin%20in%20Hyponatremic%20Patients%20with%20Heart%20Failure&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.date=1981-12-10&rft.volume=305&rft.issue=24&rft.spage=1470&rft.epage=1472&rft.pages=1470-1472&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJM198112103052412&rft_dat=%3Cproquest_cross%3E73747464%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73747464&rft_id=info:pmid/7300867&rfr_iscdi=true